Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening

Scientific Reports(2021)10.1038/s41598-021-97730-5Source: DataRank Database

Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening is a research paper published in Scientific Reports (2021). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 0.07)OA: goldTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

E. Albiasu-Arteta,Aina Anton ORCID,Laura de la Puente-Ovejero ORCID,Iker García ORCID,G. González-Iglesias ORCID

Live enrichment

PubMed:34521928 PMC:PMC8440673 OpenAlex:https://openalex.org/W3008200545

FWCI

0.07

Citation Percentile

0.4%

Influential Citations

Citation Trend

2024

goldLicense: cc-by

journalhttps://www.nature.com/articles/s41598-021-97730-5.pdf

GOLDhttps://www.nature.com/articles/s41598-021-97730-5.pdf

publisherhttps://www.nature.com/articles/s41598-021-97730-5.pdf

publisherhttps://www.nature.com/articles/s41598-021-97730-5

journalhttps://doi.org/10.1038/s41598-021-97730-5

Fields of Study

CRISPR and Genetic EngineeringMuscle Physiology and DisordersViral Infectious Diseases and Gene Expression in InsectsBiologyMedicine3' Untranslated RegionsCRISPR-Cas SystemsCells, CulturedCytoskeletal ProteinsDrug DiscoveryDystroglycansDystrophinGene EditingHEK293 CellsHumansMuscular Dystrophy, DuchenneMyoblastsMyogenic Regulatory Factor 5Primary Cell CultureSarcoglycansUtrophin

MeSH Terms

Gene EditingCells, CulturedCytoskeletal ProteinsHumansDystrophinMuscular Dystrophy, Duchenne3' Untranslated RegionsMyoblastsDystroglycansSarcoglycansUtrophinMyogenic Regulatory Factor 5Drug DiscoveryHEK293 CellsPrimary Cell CultureCRISPR-Cas Systems

Keywords

Duchenne muscular dystrophyUtrophinDystrophinCRISPRExon skippingExonGeneMuscular dystrophyComputational biologyBiologyGenome editingBioinformaticsGeneticsAlternative splicing

Sustainable Development Goals

SDG 0: Good health and well-being

Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening

FAIR Checklist

Authors (12)

Impact

Open Access

Topics

Annotations (Europe PMC)